Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 5-chloro-n-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide | 2112809-98-8 | 98.4% | 384.83 | C16H17ClN2O5S | 100 MG
SDP

Catalog No. 5000228145
Encompass_Preferred

JC-171 is a small-molecule research compound that selectively inhibits the NLRP3 inflammasome and reduces LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages (IC50 8.45 μM). It is supplied as a high-purity powder for laboratory research and in vivo studies.

  • Selective NLRP3 inflammasome inhibitor.
  • Inhibits LPS/ATP-induced IL-1β release (IC50 8.45 μM).
  • High purity (98.4%) and defined molecular weight (384.83).
  • Recommended storage: powder stability at -20°C (3 years) and 4°C (2 years).
  • Supplied as a 100 MG powder for research use.

Catalog No. 50-002-28145 Supplier Medchemexpress LLC Supplier No. HY117432100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

JC-171 is a small-molecule research compound that selectively inhibits the NLRP3 inflammasome and reduces LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages (IC50 8.45 μM). It is supplied as a high-purity powder for laboratory research and in vivo studies.

  • Selective NLRP3 inflammasome inhibitor.
  • Inhibits LPS/ATP-induced IL-1β release (IC50 8.45 μM).
  • High purity (98.4%) and defined molecular weight (384.83).
  • Recommended storage: powder stability at -20°C (3 years) and 4°C (2 years).
  • Supplied as a 100 MG powder for research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.